PDCD1 and cholangiocarcinoma: In addition, CCA cell sub-populations demonstrated heterogeneous metabolic and signal transduction activities, in which some CCA cells showed highly activated PD1/PDL1 axis signals, justifying the application of anti-PD1 combining therapy in CCA patients.